Inline Pharmaceuticals
Applying Innovative Health
Inline Pharmaceuticals
Applying Innovative Health
Applying Innovative Health
Applying Innovative Health
Inline Pharmaceuticals collaborates with CSIR IICT for Research in Novel Drug Delivery Systems
>Inline Pharmaceuticals acquires 2 established API/ Intermediary Units and R&D Lab scale product development facility in the heart of the city - 2021
>Inline Pharmaceuticals has a new facility for manufacturing of India's 1st Opaque gummies, SYNbiotics Chocolates and Sublingual strips-2022
> Inline Pharmaceuticals has a new division - IP foods Division- 2022
>IP foods division registers TM for -2022 March
a. GO! Gummies- India's 1st Opaque gummies in encapsulated flavors, colors and 100% vegan
b. SYN - India's 1st pre & probiotics chocolates with unique proprietary strains focusing on gut health, immunity, cologne health, heart health, kids health etc.
>Inline Pharmaceuticals ventures into IV fluids partnering with Harsh Medicose and Realcade 2023
>Inline Pharmaceuticals acquires formulations unit - tablets, capsules, liquid orals for exports to 5 countries - 2024
>Finalization of IV fluids manufacturing unit in Kenya with Europe VC firm
>Inline Pharmaceuticals collaborates with SK Healthcare for enhancing production capacities of Gummies and other nutraceutical products - 2024
>Inline Pharmaceuticals collaborates with Seasons Healthcare for enhancing production capacities of Finished formulations of Pharmaceutical products for exports
With more than 3 decades of Global expertise, the founders of Inline Pharmaceuticals started this journey with a vision to excel as a globally respected Pharmaceutical company. Inline Pharmaceuticals is committed to promote highly innovative products, health and wellbeing. With a modest start in commodity trading pertaining to exports and import Inline Pharmaceuticals today has reputed Global pharma companies as Clientele.
Inline Pharmaceuticals team has enriched experience in the areas of manufacturing, global sales, networking, launching unique product line with over $500 million USD business transactions globally till date. Started as a 2-member team, IP now asserts a consolidated growing team and network of employees, advisors, consultants and partners across the globe.
Reckoned by an established network and associations with global business houses and influential decision makers it was imperative for Inline Pharmaceuticals to move in to the international league of business. The idea that started as a mere trading initiative in pharma business, today has reached the echelons of setting up manufacturing units with USFDA norms.
The established global network of top management in Inline Pharmaceuticals has empowered to ink partnerships with reputed Indian and global pharmaceutical companies by signing up business exports and product manufacturing exclusivity. Having experienced success in a short span, and mapping the global pharma market scenario backed up by trusted market intelligence reports, Inline Pharmaceuticals has now laid a strong foundation to establish its own manufacturing units for Global supplies.
Today Inline Pharmaceuticals has accolades for partnering with some of the finest pharmaceutical companies across the globe and is passionate about creating a positive impact for its clients in the global scenario. In a short span of time, Inline has expanded its reach to LATAM, APAC, EMEAC and Australia.
IP believes that Innovation and Health are strongly interconnected.
Our Team is focused on the emerging trends in innovative health domain that is niche and makes sure that we are there even before someone reaches to step one.
As part of quest for innovation, we have partnered with renowned scientists and R&D labs for nanotechnology, metal isolation from plants, application service labs and many more institutions at national and international level. As we progress, our intention is to dedicate our thoughts towards understanding genetic diseases, engaging in antibacterial research and cellular therapies as well.
Inline Pharmaceuticals believes in the niche space of business that creates a lasting impact globally and on the society. From this perspective we have created products using existing molecules and formulations and converted them into path breaking drug discovery system and technology ‘Oral Dissolving Strips’(ODS) or ‘Oral Dissolving Film’(ODF) or ‘Oral Thin Films’ (OTF) and ’Nutritional Value Gummies’.
The global market is expected to cross $6000 million by 2025 with USA alone growing at a CAGR of high 13.0% during 2018 and 2026 in the OTF industry. Currently our researched product range with approved international certifications and accreditations is more than 50 ready to use products both in Natural & Allopathic human pharmaceuticals. Our global leadership team is always on the move to collaborate and ink partnerships to see exponential growth to the organization and in the process be responsible for the society we live in.
We have completely integrated R&D, technology and engineering Capabilities that enable us to be cost-effective partners on a sustainable basis.We have built strong alliances and continuing relationships with top global companies to offer R&D and formulation/product development services. Inline Pharmaceuticals group’s professionals work hand-in-hand with Business Development to identify and pursue high-potential pharma products that address unmet market needs.
With a growing talent pool supported by strong R&D investment, Inline pharmaceuticals has strengthened its ability to license Innovative products at all stages of the development cycle and in a wide range of pharmaceutical areas. Our employees have a wealth of knowledge beyond those areas in which they currently work, allowing teams to easily adapt to specific needs and opportunities as they come.
Inline Pharmaceuticals has partnered with some of the top Pharmaceutical & Novel Drug Delivery Companies to export APIs and finished formulations. However, the new addition being cosmetics for global brands and exports. IPs group companies have own manufacturing units in Oral Thin Films, API/ Bulk Drug Units, Pellets and Nanotechnology with cosmetics manufacturing being a new addition.
Oral Thin Film Products
Nutraceuticals
Pharmaceuticals
Ayurveda
Gummies - 100% Vegan
Nutraceuticals
Make in India - 1st of its kind 2 layered Opaque Gummies
Sign up to receive updates, news, and more.
New Manufacturing Facility - Sy. No. 40, Kolkupally, Madgula, Ranga Reddi,
Telangana - 509 327
B5, TIE Phase II, Balanagar Industrial Estate, Balanagar, Hyderabad 500037, Telangana, India
Monday - Saturday: 9am - 8pm
Sunday: Closed
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.